Peptides for Therapy and Diagnosis of Alzheimer’s Disease

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder with devastating effects. The greatest risk factor to develop AD is age. Today, only symptomatic therapies are available. Additionally, AD can be diagnosed with certainty only post mortem, whereas the diagnosis “probable AD” can be...

Descripción completa

Detalles Bibliográficos
Autores principales: Funke, Susanne Aileen, Willbold, Dieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426787/
https://www.ncbi.nlm.nih.gov/pubmed/22236121
http://dx.doi.org/10.2174/138161212799277752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426787/
https://www.ncbi.nlm.nih.gov/pubmed/22236121
http://dx.doi.org/10.2174/138161212799277752

Ejemplares similares